Angiogenic and Inflammatory Markers of Cardiopulmonary Changes in Children and Adolescents with Sickle Cell Disease

被引:54
作者
Niu, Xiaomei [1 ]
Nouraie, Mehdi [1 ]
Campbell, Andrew [4 ]
Rana, Sohail [1 ]
Minniti, Caterina P. [5 ]
Sable, Craig [3 ]
Darbari, Deepika [2 ]
Dham, Niti [3 ]
Reading, N. Scott [6 ,7 ]
Prchal, Josef T. [6 ,7 ]
Kato, Gregory J. [5 ]
Gladwin, Mark T. [8 ,9 ]
Castro, Oswaldo L. [1 ]
Gordeuk, Victor R. [1 ]
机构
[1] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA
[2] Childrens Natl Med Ctr, Dept Hematol, Washington, DC 20010 USA
[3] Childrens Natl Med Ctr, Dept Cardiol, Washington, DC 20010 USA
[4] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA
[5] Natl Heart Lung & Blood Inst, Pulm & Vasc Med Branch, Ctr Clin, NIH, Bethesda, MD USA
[6] Univ Utah, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA
[7] Univ Utah, Vet Adm Hosp, Salt Lake City, UT USA
[8] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA
[9] Univ Pittsburgh, Hemostasis & Vasc Biol Res Inst, Pittsburgh, PA USA
来源
PLOS ONE | 2009年 / 4卷 / 11期
基金
美国国家卫生研究院;
关键词
PULMONARY ARTERIAL-HYPERTENSION; REGURGITANT JET VELOCITY; GENE-EXPRESSION; PULSE OXIMETRY; RISK-FACTOR; HEMOLYSIS; DEATH; VEGF; ENDOTHELIUM; ACTIVATION;
D O I
10.1371/journal.pone.0007956
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Pulmonary hypertension and left ventricular diastolic dysfunction are complications of sickle cell disease. Pulmonary hypertension is associated with hemolysis and hypoxia, but other unidentified factors are likely involved in pathogenesis as well. Design and Methods: Plasma concentrations of three angiogenic markers (fibroblast growth factor, platelet derived growth factor-BB [PDGF-BB], vascular endothelial growth factor [VEGF]) and seven inflammatory markers implicated in pulmonary hypertension in other settings were determined by Bio-Plex suspension array in 237 children and adolescents with sickle cell disease at steady state and 43 controls. Tricuspid regurgitation velocity (which reflects systolic pulmonary artery pressure), mitral valve E/Edti ratio (which reflects left ventricular diastolic dysfunction), and a hemolytic component derived from four markers of hemolysis and hemoglobin oxygen saturation were also determined. Results: Plasma concentrations of interleukin-8, interleukin-10 and VEGF were elevated in the patients with sickle cell disease compared to controls (P <= 0.003). By logistic regression, greater values for PDGF-BB (P = 0.009), interleukin-6 (P = 0.019) and the hemolytic component (P = 0.026) were independently associated with increased odds of elevated tricuspid regurgitation velocity while higher VEGF concentrations were associated with decreased odds (P = 0.005) among the patients with sickle cell disease. These findings, which are consistent with reports that PDGF-BB stimulates and VEGF inhibits vascular smooth muscle cell proliferation, did not apply to E/Etdi. Conclusions: Circulating concentrations of angiogenic and pro-Inflammatory markers are altered in sickle cell disease children and adolescents with elevated tricuspid regurgitation velocity, a subgroup that may be at risk for developing worsening pulmonary hypertension. Further studies to understand the molecular changes in these children are indicated.
引用
收藏
页数:9
相关论文
共 61 条
[1]   Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension [J].
Ataga, Kenneth, I ;
Moore, Charity G. ;
Hillery, Cheryl A. ;
Jones, Susan ;
Whinna, Herbert C. ;
Strayhorn, Dell ;
Sohier, Cathy ;
Hinderliter, Alan ;
Parise, Leslie, V ;
Orringer, Eugene P. .
HAEMATOLOGICA, 2007, 93 (01) :20-26
[2]   Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion [J].
Belcher, JD ;
Marker, PH ;
Weber, JP ;
Hebbel, RP ;
Vercellotti, GM .
BLOOD, 2000, 96 (07) :2451-2459
[3]  
Bourantas KL, 1998, EUR J HAEMATOL, V61, P49
[4]   Soluble CD40 ligand in pulmonary arterial hypertension -: Possible pathogenic role of the interaction between platelets and endothelial cells [J].
Damås, JK ;
Otterdal, K ;
Yndestad, A ;
Aass, H ;
Solum, NO ;
Froland, SS ;
Simonsen, S ;
Aukrust, P ;
Andreassen, AK .
CIRCULATION, 2004, 110 (08) :999-1005
[5]   Chemokine RANTES in severe pulmonary arterial hypertension [J].
Dorfmüller, P ;
Zarka, V ;
Durand-Gasselin, I ;
Monti, G ;
Balabanian, K ;
Garcia, G ;
Capron, F ;
Coulomb-Lherminé, A ;
Marfaing-Koka, A ;
Simonneau, G ;
Emilie, D ;
Humbert, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (04) :534-539
[6]   Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease [J].
Duits, AJ ;
Rojer, RA ;
van Endt, T ;
Mac Gillavry, MR ;
ten Cate, H ;
Brandjes, DPM ;
Schnog, JB .
ANNALS OF HEMATOLOGY, 2003, 82 (03) :171-174
[7]   Regulation of angiogenesis by oxygen sensing mechanisms [J].
Fong, Guo-Hua .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2009, 87 (06) :549-560
[8]   Pulmonary hypertension in TNF-α-overexpressing mice is associated with decreased VEGF gene expression [J].
Fujita, M ;
Mason, RJ ;
Cool, C ;
Shannon, JM ;
Hara, N ;
Fagan, KA .
JOURNAL OF APPLIED PHYSIOLOGY, 2002, 93 (06) :2162-2170
[9]   Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [J].
Fulton, D ;
Gratton, JP ;
McCabe, TJ ;
Fontana, J ;
Fujio, Y ;
Walsh, K ;
Franke, TF ;
Papapetropoulos, A ;
Sessa, WC .
NATURE, 1999, 399 (6736) :597-601
[10]   Pulmonary hypertension as a risk factor for death in patients with sickle cell disease [J].
Gladwin, MT ;
Sachdev, V ;
Jison, ML ;
Shizukuda, Y ;
Plehn, JF ;
Minter, K ;
Brown, B ;
Coles, WA ;
Nichols, JS ;
Ernst, I ;
Hunter, LA ;
Blackwelder, WC ;
Schechter, AN ;
Rodgers, GP ;
Castro, O ;
Ognibene, FP .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (09) :886-895